Compare AMCX & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMCX | TLRY |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 492.0M | 533.5M |
| IPO Year | 2011 | 2018 |
| Metric | AMCX | TLRY |
|---|---|---|
| Price | $9.11 | $2.35 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $9.50 | $5.72 |
| AVG Volume (30 Days) | 687.2K | ★ 4.3M |
| Earning Date | 11-09-2026 | 10-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 132.55 | 55.69 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,311,801,000.00 | N/A |
| Revenue This Year | $5.04 | $20.44 |
| Revenue Next Year | N/A | $5.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.47 | $0.77 |
| 52 Week High | $12.93 | $15.70 |
| Indicator | AMCX | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 28.52 |
| Support Level | $7.34 | N/A |
| Resistance Level | $10.58 | $3.00 |
| Average True Range (ATR) | 0.49 | 0.16 |
| MACD | 0.23 | 0.00 |
| Stochastic Oscillator | 69.41 | 2.96 |
AMC Global Media owns several linear TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network,reached 55 million pay TV households in the US at the end of 2025. The firm also had nearly 10.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.
Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.